{"id":"NCT01285323","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma","officialTitle":"A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2011-01-28","resultsPosted":"2016-06-27","lastUpdate":"2021-11-09"},"enrollment":464,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Eosinophilic Asthma"],"interventions":[{"type":"DRUG","name":"Reslizumab","otherNames":["Cinquil","humanized monoclonal antibody","CEP-38072"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Reslizumab 3.0 mg/kg","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to determine whether reslizumab is more effective than placebo in reducing the number of clinical asthma exacerbations (CAEs) in patients with eosinophilic asthma.","primaryOutcome":{"measure":"Frequency of Clinical Asthma Exacerbations (CAEs) During 12 Months of Treatment","timeFrame":"Day 1 to Month 12","effectByArm":[{"arm":"Placebo","deltaMin":2.115,"sd":null},{"arm":"Reslizumab 3.0 mg/kg","deltaMin":0.859,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":10},"locations":{"siteCount":104,"countries":["United States","Argentina","Brazil","Canada","France","Germany","Greece","Mexico","Peru","Romania","Russia","Slovakia","South Korea","Taiwan","Ukraine"]},"refs":{"pmids":["31626990","31262379","30964365","30346831","30193936","28159511","25736990"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":232},"commonTop":["Asthma","Nasopharyngitis","Headache","Upper respiratory tract infection","Back pain"]}}